167 related articles for article (PubMed ID: 27647227)
1. Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Lee S; Jung Y; Bae Y; Yun SP; Kim S; Jo H; Seo HI
Tumori; 2017 Mar; 103(2):187-192. PubMed ID: 27647227
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
3. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
Wang L; Guo J; Lu J
Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
[TBL] [Abstract][Full Text] [Related]
4. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
Wang Z; Xu M; Hu Z; Shrestha UK
Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
[TBL] [Abstract][Full Text] [Related]
11. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T
BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109
[TBL] [Abstract][Full Text] [Related]
12. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
[TBL] [Abstract][Full Text] [Related]
13. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
14. Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.
Lee JI; Yu JH; Anh SG; Lee HW; Jeong J; Lee KS
Oncologist; 2019 Aug; 24(8):e653-e661. PubMed ID: 30679317
[TBL] [Abstract][Full Text] [Related]
15. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring.
Mantovani A; Rigamonti A; Bonapace S; Bolzan B; Pernigo M; Morani G; Franceschini L; Bergamini C; Bertolini L; Valbusa F; Rigolon R; Pichiri I; Zoppini G; Bonora E; Violi F; Targher G
Diabetes Care; 2016 Aug; 39(8):1416-23. PubMed ID: 27222503
[TBL] [Abstract][Full Text] [Related]
19. Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.
Hsieh CJ; Wang PW; Hu TH
PLoS One; 2015; 10(6):e0127521. PubMed ID: 26042596
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study.
Bjørnå ER; Engelsen MT; El-Serag HB; Ness-Jensen E
Scand J Gastroenterol; 2023 May; 58(5):505-511. PubMed ID: 36314512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
